Published in Am J Nephrol on December 19, 2013
The Effects of Obesity and Protein Intake on the Kidney | NCT00244790
Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease? Clin J Am Soc Nephrol (2015) 0.83
Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis (2014) 0.82
Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality. Clin J Am Soc Nephrol (2015) 0.81
Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int (2016) 0.80
The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant (2015) 0.79
Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis. PLoS One (2016) 0.79
Iohexol clearance for determination of glomerular filtration rate in rats induced to acute renal failure. PLoS One (2015) 0.78
Effect of large weight reductions on measured and estimated kidney function. BMC Nephrol (2017) 0.75
Renal Function in Type 2 Diabetes Following Gastric Bypass. Dtsch Arztebl Int (2016) 0.75
Bariatric Surgery and Kidney-Related Outcomes. KI Rep (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition (1992) 16.89
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis (2000) 4.44
GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis (2006) 3.81
Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med (2013) 2.99
Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98
The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol (2003) 2.66
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol (2008) 2.35
Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest (1999) 2.27
Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant (2005) 2.14
Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr (1989) 1.96
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 1.86
Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol (2012) 1.80
Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) (2009) 1.77
Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis (2010) 1.64
The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem (2007) 1.49
Independent influence of dietary protein on markers of kidney function and disease in obesity. Kidney Int (2010) 1.48
Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Soc Nephrol (2008) 1.40
Body composition and energy metabolism following Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2010) 1.16
Measured GFR as "gold standard"--all that glitters is not gold? Clin J Am Soc Nephrol (2011) 1.08
Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis (2009) 1.03
Acute kidney injury following bariatric surgery. Obes Surg (2013) 0.99
SCr and SCysC concentrations before and after traumatic amputation in male soldiers: a case-control study. Am J Kidney Dis (2013) 0.91
Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract (2010) 0.88
Bariatric surgery: impact on body composition after Roux-en-Y gastric bypass. Obes Surg (2012) 0.87
Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis (2012) 0.86
Acute kidney injury in the critically ill, morbidly obese patient: diagnostic and therapeutic challenges in a unique patient population. Crit Care Clin (2010) 0.83
Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study. Am J Kidney Dis (2013) 0.80
The importance of considering metabolism when indexing the GFR. Am J Kidney Dis (2010) 0.79
The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation. Nephrol Dial Transplant (2013) 0.78
Elevated metabolic rates in obesity. Lancet (1978) 0.77
The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg (2004) 1.77
Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int (2003) 1.70
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol (2012) 1.58
Independent influence of dietary protein on markers of kidney function and disease in obesity. Kidney Int (2010) 1.48
Medium-term follow-up confirms the safety and durability of laparoscopic ventral hernia repair with PTFE. Surgery (2003) 1.44
Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus. J Gastrointest Surg (2002) 1.31
Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol (2005) 1.21
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2010) 1.18
An integrated pharmacokinetics ontology and corpus for text mining. BMC Bioinformatics (2013) 1.17
Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int (2004) 1.16
A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc (2010) 1.15
Laparoscopic era of operations for morbid obesity. Arch Surg (2003) 1.15
Laparoscopic sleeve gastrectomy for super obese patients: forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg (2012) 1.09
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis (2006) 1.08
Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin J Am Soc Nephrol (2010) 1.07
Comparison of hand-sewn, linear-stapled, and circular-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg (2011) 1.04
Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg (2004) 1.03
Iatrogenic intestinal and mesenteric injuries with small bowel volvulus following use of barbed suture during laparoscopic myomectomy. J Laparoendosc Adv Surg Tech A (2013) 1.03
Non-compartment model to compartment model pharmacokinetics transformation meta-analysis--a multivariate nonlinear mixed model. BMC Syst Biol (2010) 1.00
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite. Drug Metab Dispos (2009) 0.99
Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients. Ann Surg (2008) 0.99
Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis (2006) 0.99
Internal hernia formation after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Am Surg (2002) 0.96
Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin Cancer Res (2003) 0.96
Literature mining on pharmacokinetics numerical data: a feasibility study. J Biomed Inform (2009) 0.93
Comparing mandated health care reforms: the Affordable Care Act, accountable care organizations, and the Medicare ESRD program. Clin J Am Soc Nephrol (2012) 0.92
Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. Ann Surg (2010) 0.91
Effectiveness of implementing a wake up and breathe program on sedation and delirium in the ICU. Crit Care Med (2014) 0.90
Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. J Urol (2007) 0.89
Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract (2010) 0.88
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Am J Perinatol (2012) 0.87
A new probabilistic rule for drug-dug interaction prediction. J Pharmacokinet Pharmacodyn (2009) 0.86
A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis. Am J Kidney Dis (2009) 0.85
Absorbable versus nonabsorbable mesh repair of congenital diaphragmatic hernias in a growing animal model. J Laparoendosc Adv Surg Tech A (2011) 0.85
Using simulation to assess the influence of race and insurer on shared decision making in periviable counseling. Simul Healthc (2014) 0.85
A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic. J Matern Fetal Neonatal Med (2011) 0.83
Bone density in children with single ventricle physiology. Pediatr Cardiol (2014) 0.81
Utility of formalin-fixed, paraffin-embedded liver biopsy specimens for global proteomic analysis in nonalcoholic steatohepatitis. Proteomics Clin Appl (2011) 0.80
CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modeling. Drug Metab Dispos (2013) 0.80
Acute changes in renal function after laparoscopic gastric surgery for morbid obesity. Surg Obes Relat Dis (2006) 0.80
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats. Drug Metab Dispos (2010) 0.79
Gastric bypass for morbid obesity in patients 50 years or older: is laparoscopic technique safer? Am Surg (2003) 0.78
Incidence of gastrojejunostomy stricture in laparoscopic Roux-en-Y gastric bypass using an autologous fibrin sealant. Obes Surg (2014) 0.78
50 years of research and discovery in chronic kidney disease and mineral & bone disorder: the central role of phosphate. Kidney Int Suppl (2011) 0.78
Deep sedation in natural orifice transluminal endoscopic surgery (NOTES): a comparative study with dogs. Surg Endosc (2012) 0.77
Distension-induced gastric contraction is attenuated in an experimental model of gastric restraint. Obes Surg (2010) 0.76
Laparoscopic sleeve gastrectomy is safe and effective in elderly patients: a comparative analysis. Obes Surg (2015) 0.76
The mini-fellowship concept: a six-week focused training program for minimally invasive bariatric surgery. Surg Endosc (2007) 0.76
Female pelvic floor symptoms before and after bariatric surgery. Obes Surg (2012) 0.75
Adolescent bariatric surgery. Surg Clin North Am (2011) 0.75
Renal function and bisphosphonate safety. J Bone Miner Res (2008) 0.75
Lifting the unbearable weight of morbid obesity. Ann Surg (2008) 0.75
Influence of peri-duodenal non-constrictive cuff on the body weight of rats. Obes Surg (2015) 0.75
Comment on: Favorable internal hernia rate achieved using retrocolic, retrogastric alimentary limb in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis (2010) 0.75
Laparoscopic repair of umbilical hernias in conjunction with other laparoscopic procedures. JSLS (2006) 0.75
Efficacy of a laparoscopic gastric restrictive device in an obese canine model. Obes Surg (2014) 0.75
Capillary electrophoresis of the proteolytic activity of the stratum corneum obtained by tape stripping. Electrophoresis (2010) 0.75
Roux limb volvulus after long-limb Roux-en-Y gastric bypass. Obes Surg (2007) 0.75
What is wrong with the training of general surgery? Adv Surg (2014) 0.75
Response of gut hormones after implantation of a reversible gastric restrictive device in different animal models. J Surg Res (2012) 0.75
Reversible gastric restriction implant: safety and efficacy in a canine model. Obes Surg (2011) 0.75
Management of gastrointestinal disorders in the bariatric patient. Med Clin North Am (2007) 0.75